We are live on ! Find out more
BMRN icon

BioMarin Pharmaceuticals
BMRN

537 hedge funds and large institutions have $16.1B invested in BioMarin Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 98 funds opening new positions, 195 increasing their positions, 172 reducing their positions, and 53 closing their positions.

New
Increased
Maintained
Reduced
Closed

85% more first-time investments, than exits

New positions opened: 98 | Existing positions closed: 53

29% more call options, than puts

Call options by funds: $319M | Put options by funds: $247M

18% more capital invested

Capital invested by funds: $13.6B → $16.1B (+$2.51B)

13% more repeat investments, than reductions

Existing positions increased: 195 | Existing positions reduced: 172

8% more funds holding

Funds holding: 496 → 537 (+41)

1.66% more ownership

Funds ownership: 98.96% → 100.62% (+1.7%)

13% less funds holding in top 10

Funds holding in top 10: 8 → 7 (-1)

Holders
537
Holders Change
+41
Holders Change %
+8.27%
% of All Funds
9.5%
Holding in Top 10
7
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-12.5%
% of All Funds
0.12%
New
98
Increased
195
Reduced
172
Closed
53
Calls
$319M
Puts
$247M
Net Calls
+$72M
Net Calls Change
+$40.7M

Top Buyers

Rank Fund Capital Flow
1
Dodge & Cox
Dodge & Cox
California
+$165M
2
Ameriprise
Ameriprise
Minnesota
+$107M
3
Parnassus Investments
Parnassus Investments
California
+$106M
4
APM
Avidity Partners Management
Texas
+$78.7M
5
CTA
Carillon Tower Advisers
Florida
+$64.6M

Top Sellers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
-$58.5M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$46.7M
3
MWNA
Marshall Wace North America
New York
-$46.6M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$44.6M
5
N
Nuveen
North Carolina
-$42.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
LP
201
LMR Partners
United Kingdom
$2.5M +$2.26M +28,500 New
ANI
202
American National Insurance
Texas
$2.46M – – –
OAM
203
Oppenheimer Asset Management
New York
$2.4M +$108K +1,365 +5%
WIA
204
Wealthstreet Investment Advisors
Texas
$2.38M +$216K +2,720 +11%
Comerica Bank
205
Comerica Bank
Texas
$2.38M +$225K +2,838 +12%
LSA
206
Leonteq Securities AG
Switzerland
$2.37M +$2.14M +26,998 New
Robeco Institutional Asset Management
207
Robeco Institutional Asset Management
Netherlands
$2.34M -$1.66M -20,937 -44%
Mercer Global Advisors
208
Mercer Global Advisors
Colorado
$2.33M +$24.9K +314 +1%
ECM
209
ExodusPoint Capital Management
New York
$2.32M -$1.07M -13,494 -34%
TMAM
210
Tokio Marine Asset Management
Japan
$2.31M -$62.5K -788 -3%
Public Employees Retirement Association of Colorado
211
Public Employees Retirement Association of Colorado
Colorado
$2.3M -$15.6M -197,133 -88%
Thrivent Financial for Lutherans
212
Thrivent Financial for Lutherans
Minnesota
$2.27M +$153K +1,925 +8%
QIM
213
Quantitative Investment Management
Virginia
$2.26M +$2.04M +25,775 New
IAS
214
IMA Advisory Services
Colorado
$2.24M -$678K -8,553 -25%
Connor, Clark & Lunn Investment Management (CC&L)
215
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$2.23M +$1.29M +16,284 +179%
SO
216
STRS Ohio
Ohio
$2.22M -$3.36M -42,357 -63%
Mariner
217
Mariner
Kansas
$2.22M +$786K +9,919 +64%
BMSSC
218
B. Metzler seel. Sohn & Co
Germany
$2.21M +$2.01M +25,387 New
VMPIC
219
Varma Mutual Pension Insurance Co
Finland
$2.19M -$1.98M -25,000 -50%
AAP
220
Aristotle Atlantic Partners
Florida
$2.19M – – –
PHP
221
Parkman Healthcare Partners
Connecticut
$2.19M +$1.98M +25,000 New
JG
222
Jefferies Group
New York
$2.11M +$1.9M +23,917 +13,589%
Janney Montgomery Scott
223
Janney Montgomery Scott
Pennsylvania
$2.09M -$530K -6,682 -22%
SIA
224
Sit Investment Associates
Minnesota
$2.06M – – –
CSS
225
Cubist Systematic Strategies
Connecticut
$2.06M +$1.02M +12,866 +121%
7 8
9
10 11

BMRN Hedge Fund Activity: Q4 2020 in Review

537 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in BioMarin Pharmaceuticals (BMRN) for Q4 2020, worth a combined $16.1B — up 18% from $13.6B a quarter earlier.

Buyers outnumbered sellers: 98 funds opened new BMRN positions and 53 closed out — a net gain of 45 holders — while 195 added to existing stakes and 172 trimmed.

The largest buyer was Dodge & Cox, adding an estimated $165M. The largest seller was JP Morgan Chase, cutting an estimated $58.5M.

  • 537 institutional investors held BioMarin Pharmaceuticals (BMRN) as of Q4 2020, up from 496 in Q3 2020.
  • Funds reported $16.1B of BioMarin Pharmaceuticals stock for Q4 2020, up 18% quarter-over-quarter.
  • 98 funds opened new BioMarin Pharmaceuticals positions in Q4 2020 and 53 closed out, a net change of +45 holders.
  • The largest BioMarin Pharmaceuticals buyer in Q4 2020 was Dodge & Cox, an estimated $165M added.
  • The largest BioMarin Pharmaceuticals seller in Q4 2020 was JP Morgan Chase, an estimated $58.5M sold.

Based on aggregated 13F filings for Q4 2020.